Protara Therapeutics Inc.
4.70
-0.33 (-6.56%)
At close: Jan 15, 2025, 3:59 PM
4.58
-2.55%
After-hours Jan 15, 2025, 05:48 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.95M n/a n/a
Cost of Revenue 341.00K 247.00K 1.17M 196.00K 16.00K 115.00K 148.00K 123.00K 57.00K n/a 27.00K 57.00K
Gross Profit -341.00K -247.00K -1.17M -196.00K -16.00K -115.00K -148.00K -123.00K -57.00K 2.95M -27.00K -57.00K
Operating Income -43.61M -67.06M -47.49M -34.44M -15.25M -26.08M -30.36M -28.70M -20.87M -7.58M -7.12M -8.00M
Interest Income 2.73M 1.11M 237.00K 466.00K n/a n/a n/a n/a n/a n/a 4.00K 20.00K
Pretax Income -40.42M -65.95M -47.25M -33.98M -14.99M -25.44M -29.96M -28.53M -21.38M -3.34M -7.91M -7.97M
Net Income -40.42M -64.81M -47.13M -33.51M -14.73M -25.44M -29.96M -28.53M -21.38M -3.34M -7.91M -7.97M
Selling & General & Admin 18.62M 20.74M 26.40M 22.46M 8.82M 10.57M 8.53M 9.71M 8.43M 4.10M 3.10M 2.03M
Research & Development 24.79M 16.81M 21.09M 11.98M 6.44M 15.51M 21.69M 18.87M 12.38M 6.43M 3.99M 5.91M
Other Expenses n/a 29.52M n/a n/a n/a 207.00K n/a n/a n/a n/a n/a n/a
Operating Expenses 43.61M 37.55M 47.49M 34.44M 15.25M 26.08M 30.21M 28.58M 20.81M 10.53M 7.09M 7.94M
Interest Expense n/a 1.14M 1.74M 34.00K n/a n/a 259.00K 193.00K 144.00K 857.00K 861.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a 8.42M -123.00K -57.00K n/a n/a n/a
Cost & Expenses 43.61M 37.55M 47.49M 34.44M 15.25M 26.08M 30.36M 28.70M 20.87M 10.53M 7.12M 8.00M
Income Tax n/a -1.14M -117.00K -466.00K -262.00K 5.35M 657.00K 372.00K -363.00K 5.09M n/a n/a
Shares Outstanding (Basic) 11.33M 11.26M 11.23M 7.23M 64.44K 2.56M 431.86K 414.04K 411.60K 76.61K 374.85K 374.85K
Shares Outstanding (Diluted) 11.33M 11.26M 11.23M 7.23M 64.44K 2.56M 431.86K 414.04K 411.60K 76.61K 374.85K 374.85K
EPS (Basic) -3.57 -5.76 -4.2 -4.63 -228.6 -9.93 -69.38 -68.9 -51.94 -43.62 -37.43 -37.62
EPS (Diluted) -3.57 -5.76 -4.2 -4.63 -228.6 -9.93 -69.38 -68.9 -51.94 -43.62 -37.43 -37.62
EBITDA -43.27M -64.57M -46.09M -33.78M -7.81M -20.61M -29.82M -28.40M -21.32M -2.45M -7.02M -7.91M
Depreciation & Amortization 341.00K 247.00K 1.17M 196.00K 16.00K 115.00K 148.00K 123.00K 57.00K 30.00K 27.00K 57.00K